Trial for sudden hearing loss within days
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial is for adults who develop sudden hearing loss over a very short time window, confirmed by a hearing test. It aims to study the sudden hearing loss condition and whether the study approach can help people recover hearing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 21 or older
- Have sudden hearing loss that started within the past 3 days
- Your hearing test should show a drop of 30 dB or more at three nearby sound frequencies
- You must have been seen at the hospital’s ear/nose/throat (ENT) clinic and told you have sudden hearing loss
- You must read about the study and agree to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with sudden hearing loss of unknown cause to understand what makes it better or worse. Researchers will use advanced tests (like blood and imaging) to find patterns that might predict recovery.
This trial tests a combination of treatments (integrative medicine) for people who have just lost their hearing suddenly. It may help improve hearing recovery if started early.
This study tests whether a medication called hydroxychloroquine, usually used for malaria or autoimmune conditions, can help treat sudden hearing loss. It will be compared to standard steroid treatment. The goal is to see if it improves hearing recovery.
This trial tests a medicine called Yiyuancong for people who recently lost hearing in one ear suddenly. If you are between 18 and 60 years old and your hearing loss started within the last 3 days, this study may be an option.
This trial tests a new treatment for sudden, severe hearing loss that hasn't improved with standard care. A single injection of stem cell particles is given into the ear to see if it safely restores hearing.
This trial tests a new way to deliver steroid medication directly into the inner ear through the eardrum to treat sudden hearing loss in one ear. The goal is to help restore hearing after standard treatments haven't fully worked.
Hear when a new Sudden Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.